Background A non-invasive diagnostic marker of membranous nephropathy (MN) is desirable. The urinary level of podocalyxin (PCX) is higher in various glomerular diseases, including MN. The aim of this
CAP, controlled attenuation parameters; CI, confidence interval; NS, not significant; IQR/MCAP, interquartile range/median of CAP value.*Body mass index and IQR/MCAP were incorporated into multivariat
Background/Aims: Glomerular kidney disease (GKD) is suspected in patients based on proteinuria, but its diagnosis relies primarily on renal biopsy. We used urine peptide profiling as a noninvasive mea